Generation Bio Co (GBIO)

NASDAQ
5.99
+0.46(+8.32%)
After Hours
5.70
-0.29(-4.84%)
- Real-time Data
  • Volume:
    483,562
  • Day's Range:
    5.37 - 6.22
  • 52 wk Range:
    3.96 - 16.11
Unusual trading volume

Generation Bio has doubled (or more) its daily average of shares traded over the last 3 months. High volumes usually indicate new trends and larger share price movements.

GBIO Overview

Prev. Close
5.53
Day's Range
5.37-6.22
Revenue
-
Open
5.44
52 wk Range
3.96-16.11
EPS
-2.35
Volume
483,562
Market Cap
355.94M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
182,158
P/E Ratio
-2.34
Beta
1.5
1-Year Change
-59.47%
Shares Outstanding
59,422,697
Next Earnings Date
16 Mar 2023
What is your sentiment on Generation Bio?
or
Market is currently closed. Voting is open during market hours.

Generation Bio Co News

Generation Bio Co Analysis

Generation Bio Co Company Profile

Generation Bio Co Company Profile

Employees
150

Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Read More

Analyst Price Target

Average16.67 (+178.24% Upside)
High25
Low8
Price5.99
No. of Analysts6
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralBuyStrong BuyStrong BuySell
Technical IndicatorsNeutralStrong BuyStrong BuyBuyStrong Sell
SummaryNeutralStrong BuyStrong BuyStrong BuyStrong Sell